Fredun Pharmaceuticals Limited has submitted a regulatory disclosure to BSE Limited regarding the availability of the audio recording of their Q4 FY26 Earnings Conference Call.
The disclosure was made pursuant to Regulation 30 read with Sub para 15, Para A Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The earnings conference call was held on Wednesday, 10th June 2026, and covered the audited financial results of the company for both the quarter and year ended on 31st March 2026.
The audio recording is available on the company's website at the following link: http://www.fredungroup.com/investor-investor-meet.html#investor
The letter was digitally signed by Fredun Nariman Medhora, Managing Director (DIN: 01745348), on 10th June 2026 at 19:01:27 +05'30'.